Concepedia

Ayako Sugama

AS

Statistics

Publications

3

Citations

116

H-Index

3

Active since

2015

Affiliations

National Cancer Center Hospital East(Current)

Ayako Sugama is an author at National Cancer Center Hospital East specializing in medicine, oncology, and clinical trial reports.

Publications per year

2015–2019

3

Publications

3

Regorafenib plus nivolumab in patients with advanced gastric (GC) or colorectal cancer (CRC): An open-label, dose-finding, and dose-expansion phase 1b trial (REGONIVO, EPOC1603).

Shota Fukuoka, Hiroki Hara, Naoki Takahashi et al. · Journal of Clinical Oncology · 2019 · 69 citations

Medicine, Oncology, Pharmacology +16

Gallic acid regulates adipocyte hypertrophy and suppresses inflammatory gene expression induced by the paracrine interaction between adipocytes and macrophages in vitro and in vivo

Miori Tanaka, Ayako Sugama, Kanako Sumi et al. · Nutrition Research · 2019 · 37 citations

Life Sciences, Biochemistry, Physiology +15

An investigator initiated multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE).

Yasutoshi Kuboki, Tomohiro Nishina, Eiji Shinozaki et al. · Journal of Clinical Oncology · 2015 · 10 citations

Medicine, Oncology, Pharmacology +15

1–3 of 3